{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:08:20Z","timestamp":1778620100110,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010553","name":"UC Davis MIND Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD036071"],"award-info":[{"award-number":["HD036071"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50 HD103526"],"award-info":[{"award-number":["P50 HD103526"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014884","name":"Zynerba Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007120","name":"King Mongkut&apos;s Institute of Technology Ladkrabang","doi-asserted-by":"publisher","award":["KREF206333"],"award-info":[{"award-number":["KREF206333"]}],"id":[{"id":"10.13039\/501100007120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jmoldx.2024.02.007","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T06:28:52Z","timestamp":1711088932000},"page":"498-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4938-1468","authenticated-orcid":false,"given":"Poonnada","family":"Jiraanont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Zafarullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda M.","family":"Espinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Randol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blythe","family":"Durbin-Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6388-9180","authenticated-orcid":false,"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2024.02.007_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/1.6.397","article-title":"DNA methylation represses FMR-1 transcription in fragile X syndrome","volume":"1","author":"Sutcliffe","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","article-title":"Absence of expression of the FMR-1 gene in fragile X syndrome","volume":"66","author":"Pieretti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/342931","article-title":"Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome","volume":"71","author":"Coffee","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ejhg.2008.130","article-title":"Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations","volume":"16","author":"Tabolacci","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib5","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/ajmg.a.36241","article-title":"Fragile X syndrome: from protein function to therapy","volume":"161A","author":"Bagni","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib6","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1093\/emboj\/20.17.4803","article-title":"The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif","volume":"20","author":"Schaeffer","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","article-title":"Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome","volume":"107","author":"Brown","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib9","doi-asserted-by":"crossref","first-page":"E11397","DOI":"10.1073\/pnas.1809588115","article-title":"Regulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation","volume":"115","author":"Liu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/hmg\/5.8.1083","article-title":"The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals","volume":"5","author":"Eberhart","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90420-U","article-title":"The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein","volume":"74","author":"Siomi","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(01)00647-5","article-title":"The fragile X mental retardation protein","volume":"56","author":"Bardoni","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn1893","article-title":"A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability","volume":"10","author":"Zalfa","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib14","series-title":"Fragile X Syndrome: Diagnosis, Treatment and Research","first-page":"3","article-title":"Physical and behavioral phenotype","author":"Hagerman","year":"2002"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib15","first-page":"1236","article-title":"A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome","volume":"147","author":"Hull","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1352\/1944-7558-117.1.1","article-title":"Behavioral phenotype of fragile X syndrome in adolescence and adulthood","volume":"117","author":"Smith","year":"2012","journal-title":"Am J Intellect Dev Disabil"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ddrr.1129","article-title":"Fragile X syndrome: an aging perspective","volume":"18","author":"Schneider","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.psychres.2012.12.022","article-title":"Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia","volume":"210","author":"Kov\u00e1cs","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4","article-title":"FMRP expression as a potential prognostic indicator in fragile X syndrome","volume":"84","author":"Tassone","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1096-8628(20001113)95:2<150::AID-AJMG11>3.0.CO;2-1","article-title":"Cognitive and behavioral profile of fragile X boys: correlations to molecular data","volume":"95","author":"Backes","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<286::AID-AJMG10>3.0.CO;2-H","article-title":"Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome","volume":"83","author":"Kaufmann","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib22","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/diagnostics11101780","article-title":"FMRP levels in human peripheral blood leukocytes correlates with intellectual disability","volume":"11","author":"Roth","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mrdd.20006","article-title":"Phenotypic variation and FMRP levels in fragile X","volume":"10","author":"Loesch","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/brainsci10100694","article-title":"A genotype-phenotype study of high-resolution FMR1 nucleic acid and protein analyses in fragile X patients with neurobehavioral assessments","volume":"10","author":"Budimirovic","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.21243","article-title":"Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP)","volume":"63","author":"Gothelf","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib27","first-page":"800","article-title":"Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome","volume":"53","author":"McConkie-Rosell","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib28","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/hmg\/6.11.1791","article-title":"Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1","volume":"6","author":"Stoger","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ajmg.1320510444","article-title":"Mosaicism in fragile X affected males","volume":"51","author":"Nolin","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib30","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM199112123252401","article-title":"Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation","volume":"325","author":"Rousseau","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/14737159.2017.1377612","article-title":"Size and methylation mosaicism in males with fragile X syndrome","volume":"17","author":"Jiraanont","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<221::AID-AJMG11>3.0.CO;2-M","article-title":"Mosaicism for a full mutation and a normal size allele in two fragile X males","volume":"84","author":"Schmucker","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1096-8628(19980724)78:4<341::AID-AJMG7>3.0.CO;2-O","article-title":"Mosaicism for full mutation and normal-sized allele of the FMR1 gene: a new case","volume":"78","author":"Orrico","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.06.2008.0139","article-title":"Fragile X mosaic male full mutation\/normal allele detected by PCR\/MS-MLPA","volume":"2009","author":"Todorov","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.884424","article-title":"De novo large deletion leading to fragile X syndrome","volume":"13","author":"Jiraanont","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib36","first-page":"225","article-title":"A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases","volume":"55","author":"Rousseau","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1399-0004.1999.550508.x","article-title":"Tissue-specific methylation differences in a fragile X premutation carrier","volume":"55","author":"Tassone","year":"1999","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib38","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/nar\/28.10.2141","article-title":"Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals","volume":"28","author":"Genc","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib39","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/hmg\/ddu032","article-title":"CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size","volume":"23","author":"Ludwig","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H","article-title":"Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA","volume":"94","author":"Tassone","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jmedgenet-2013-102021","article-title":"CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles","volume":"51","author":"Pretto","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14183-0","article-title":"Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation","volume":"12","author":"Hwang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib43","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/s41598-023-33528-x","article-title":"Clinical implications of somatic allele expansion in female FMR1 premutation carriers","volume":"13","author":"Aishworiya","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib44","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3390\/ijms22052616","article-title":"Robust detection of somatic mosaicism and repeat interruptions by long-read targeted sequencing in myotonic dystrophy type 1","volume":"22","author":"Mangin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64674","article-title":"Propensity for somatic expansion increases over the course of life in Huntington disease","volume":"10","author":"Kacher","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1022441101801","article-title":"Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA)","volume":"23","author":"Ito","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40673-016-0058-y","article-title":"Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1","volume":"3","author":"Kraus-Perrotta","year":"2016","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M","article-title":"Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"11","author":"Cancel","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fgene.2014.00318","article-title":"Clinical and molecular implications of mosaicism in FMR1 full mutations","volume":"5","author":"Pretto","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib50","article-title":"Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions","volume":"14","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R","article-title":"Transcription of the FMR1 gene in individuals with fragile X syndrome","volume":"97","author":"Tassone","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00439-004-1086-x","article-title":"A study of the distributional characteristics of FMR1 transcript levels in 238 individuals","volume":"114","author":"Allen","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib67","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11689-019-9288-7","article-title":"Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome","volume":"11","author":"Baker","year":"2019","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neubiorev.2006.09.007","article-title":"Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X","volume":"31","author":"Loesch","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib63","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/s41598-022-09633-8","article-title":"Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of fragile X protein from dried blood spots","volume":"12","author":"Boggs","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations","volume":"10","author":"Tassone","year":"2008","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome","volume":"56","author":"Filipovic-Sadic","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/brainsci9020039","article-title":"Pharmacological reactivation of the silenced FMR1 gene as a targeted therapeutic approach for fragile X syndrome","volume":"9","author":"Kumari","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1866-1955-5-8","article-title":"A quantitative homogeneous assay for fragile X mental retardation 1 protein","volume":"5","author":"Schutzius","year":"2013","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib56","doi-asserted-by":"crossref","first-page":"800","DOI":"10.5966\/sctm.2014-0278","article-title":"High-throughput screening to identify compounds that increase fragile X mental retardation protein expression in neural stem cells differentiated from fragile X syndrome patient-derived induced pluripotent stem cells","volume":"4","author":"Kumari","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib57","series-title":"Stanford Binet Intelligence Scales","author":"Gale","year":"2003"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib58","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib59","series-title":"Wechsler Adult Intelligence Scale-Fourth","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib60","series-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib64","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1261\/rna.206307","article-title":"Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models","volume":"13","author":"Garc\u00eda-Alegr\u00eda","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib68","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1399-0004.2011.01798.x","article-title":"Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome","volume":"82","author":"Lessard","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.65","article-title":"Fragile X syndrome","volume":"3","author":"Hagerman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cge.13075","article-title":"Fragile X syndrome: an overview and update of the FMR1 gene","volume":"93","author":"Mila","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251367","article-title":"Rates of protein synthesis are reduced in peripheral blood mononuclear cells (PBMCs) from fragile X individuals","volume":"16","author":"Dionne","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib72","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/jcbfm.2012.205","article-title":"Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice","volume":"33","author":"Qin","year":"2013","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104978","article-title":"Regional rates of brain protein synthesis are unaltered in dexmedetomidine sedated young men with fragile X syndrome: a L-[1-11C]leucine PET study","volume":"143","author":"Schmidt","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib74","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/ejhg.2017.55","article-title":"Gene-set analysis shows association between FMRP targets and autism spectrum disorder","volume":"25","author":"Jansen","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12929","article-title":"De novo mutations in schizophrenia implicate synaptic networks","volume":"506","author":"Fromer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib76","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/mp.2014.40","article-title":"Copy number variation in schizophrenia in Sweden","volume":"19","author":"Szatkiewicz","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib77","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41380-020-00912-2","article-title":"Genetic association of FMRP targets with psychiatric disorders","volume":"26","author":"Clifton","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2015.04.012","article-title":"Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders","volume":"165","author":"Folsom","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2040-2392-2-6","article-title":"Dysregulation of fragile \u00d7 mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study","volume":"2","author":"Fatemi","year":"2011","journal-title":"Mol Autism"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fgene.2018.00314","article-title":"Timing of expansion of fragile X premutation alleles during intergenerational transmission in a mouse model of the fragile X-related disorders","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.jmoldx.2024.02.007_bib81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/brainsci9030052","article-title":"Repeat instability in the fragile X-related disorders: lessons from a mouse model","volume":"9","author":"Zhao","year":"2019","journal-title":"Brain Sci"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:56Z","timestamp":1778616476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157824000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525157824000588"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.02.007","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}